More than just another IDH inhibitor: Insights from the HMPL-306 phase 1 trial.

Saved in:
Bibliographic Details
Title: More than just another IDH inhibitor: Insights from the HMPL-306 phase 1 trial.
Authors: Getz TM; Section of Hematology, Department of Internal Medicine, Yale University and Yale Comprehensive Cancer Center, New Haven, CT 06520, USA., Bewersdorf JP; Section of Hematology, Department of Internal Medicine, Yale University and Yale Comprehensive Cancer Center, New Haven, CT 06520, USA. Electronic address: jan.bewersdorf@yale.edu.
Source: Med (New York, N.Y.) [Med] 2025 Jun 13; Vol. 6 (6), pp. 100600.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6340
DOI:10.1016/j.medj.2025.100600